Literature DB >> 11037770

The effects of sertraline and fluoxetine on anxiety in the elevated plus-maze test in mice.

M Kurt1, A C Arik, S Celik.   

Abstract

The aim of this study was to evaluate the acute and chronic effects of two SSRIs (sertraline and fluoxetine) on anxiety by the elevated plus-maze test. Diazepam increased the time spent in open arms significantly whereas the anxiogenic m-chlorophenylpiperazine (m-CPP) decreased the time significantly. Acute sertraline (10 mg x kg(-1)) and fluoxetine (20 mg x kg(-1)) treatment significantly decreased the time spent in open arms. Acute fluoxetine (20 mg x kg(-1)) treatment also decreased the total number of enclosed arm entries. Seven days sertraline treatment decreased the time spent in open arms, whereas 14 days fluoxetine treatment increased the time spent in open arms. These results show that acute administration of SSRIs may produce anxiogenic effects in the elevated plus-maze test.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11037770     DOI: 10.1515/jbcpp.2000.11.2.173

Source DB:  PubMed          Journal:  J Basic Clin Physiol Pharmacol        ISSN: 0792-6855


  30 in total

1.  Methoxetamine affects brain processing involved in emotional response in rats.

Authors:  M T Zanda; P Fadda; S Antinori; M Di Chio; W Fratta; C Chiamulera; L Fattore
Journal:  Br J Pharmacol       Date:  2017-08-19       Impact factor: 8.739

2.  Differences in FKBP51 regulation following chronic social defeat stress correlate with individual stress sensitivity: influence of paroxetine treatment.

Authors:  Klaus V Wagner; Daria Marinescu; Jakob Hartmann; Xiao-Dong Wang; Christiana Labermaier; Sebastian H Scharf; Claudia Liebl; Manfred Uhr; Florian Holsboer; Marianne B Müller; Mathias V Schmidt
Journal:  Neuropsychopharmacology       Date:  2012-08-08       Impact factor: 7.853

3.  Blonanserin - A Novel Antianxiety and Antidepressant Drug? An Experimental Study.

Authors:  Ramchandra Prabhakar Limaye; Aditi Nitin Patil
Journal:  J Clin Diagn Res       Date:  2016-09-01

4.  Effects of acute or repeated paroxetine and fluoxetine treatment on affective behavior in male and female adolescent rats.

Authors:  Leslie R Amodeo; Venuz Y Greenfield; Danielle E Humphrey; Veronica Varela; Joseph A Pipkin; Shannon E Eaton; Jelesa D Johnson; Christopher P Plant; Zachary R Harmony; Li Wang; Cynthia A Crawford
Journal:  Psychopharmacology (Berl)       Date:  2015-07-05       Impact factor: 4.530

5.  The effects of fluoxetine and its complexes with glycerrhizic acid on behavior in rats and brain monoamine levels.

Authors:  G T Shishkina; N N Dygalo; A M Yudina; T S Kalinina; T G Tolstikova; I V Sorokina; I L Kovalenko; L V Anikina
Journal:  Neurosci Behav Physiol       Date:  2006-05

6.  Anxiety-like behaviors produced by acute fluoxetine administration in male Fischer 344 rats are prevented by prior exercise.

Authors:  Benjamin N Greenwood; Paul V Strong; Leah Brooks; Monika Fleshner
Journal:  Psychopharmacology (Berl)       Date:  2008-05-03       Impact factor: 4.530

7.  BAG1 plays a critical role in regulating recovery from both manic-like and depression-like behavioral impairments.

Authors:  Sungho Maeng; Joshua G Hunsberger; Brandon Pearson; Peixiong Yuan; Yun Wang; Yanling Wei; Joseph McCammon; Robert J Schloesser; Rulun Zhou; Jing Du; Guang Chen; Bruce McEwen; John C Reed; Husseini K Manji
Journal:  Proc Natl Acad Sci U S A       Date:  2008-06-18       Impact factor: 11.205

Review 8.  Pharmacomimetics of exercise: novel approaches for hippocampally-targeted neuroprotective agents.

Authors:  A M Stranahan; Y Zhou; B Martin; S Maudsley
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

9.  Activity of Raphé Serotonergic Neurons Controls Emotional Behaviors.

Authors:  Anne Teissier; Alexei Chemiakine; Benjamin Inbar; Sneha Bagchi; Russell S Ray; Richard D Palmiter; Susan M Dymecki; Holly Moore; Mark S Ansorge
Journal:  Cell Rep       Date:  2015-11-19       Impact factor: 9.423

Review 10.  The serotonergic system and anxiety.

Authors:  Joshua A Gordon; Rene Hen
Journal:  Neuromolecular Med       Date:  2004       Impact factor: 3.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.